Skip to content

Single-Operator Versus Dual-Operator Double-balloon Endoscopy in Patients With Small-Bowel Disorders

Prospective Trial Comparing Single-Operator and Dual-Operator Double-balloon Endoscopy in Patients With Small-Bowel Disorders

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01184690
Acronym
DBE
Enrollment
80
Registered
2010-08-19
Start date
2010-08-31
Completion date
2011-08-31
Last updated
2010-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small-Bowel Disorders

Keywords

double-balloon endoscopy, diagnostic yield

Brief summary

Double-balloon endoscopy (DBE) is a new device that allows diagnosis and treatment throughout the entire small intestine. Although the originally described method requires two operators, the investigators have recently developed a method to perform DBE by a single operator. The investigators here assessed the clinical usefulness of this one-person method in comparison to the conventional two-person DBE.

Interventions

PROCEDURESingle-operator double-balloon endoscopy

Single-operator double-balloon endoscopy

PROCEDUREdual-operator double-balloon endoscopy

dual-operator double-balloon endoscopy

Sponsors

Shanghai Changzheng Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
16 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. suspected or known small-bowel disease 2. age: 16-70

Exclusion criteria

1. pregnancy 2. coagulation disorders 3. prior surgery of the small bowel and colon

Design outcomes

Primary

MeasureTime frameDescription
completion whether the complete enteroscopy is achieved?2 hoursThe completion rate for examination of the entire small intestine
lesion-discovery2 hourslesion-discovery rate

Secondary

MeasureTime frame
observation time2 hours
Number of Participants with Adverse Events2 days

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026